Biotest GmbH & Co. KGaA (HAM:BIO0)
Germany · Delayed Price · Currency is EUR 33.20
0.00 (0.00%)
At close: Aug 14, 2026
Biotest GmbH & Co. KGaA Market Cap
Biotest GmbH & Co. KGaA has a market cap or net worth of €1.31 billion as of August 14, 2026. Its market cap has decreased by -7.00% in one year.
Market Cap
1.31B
Enterprise Value
2.06B
Revenue
648.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
€33.20
ChartMarket Cap Chart
Since January 14, 2025, Biotest GmbH & Co. KGaA's market cap has decreased from 1.37B to 1.31B, a decrease of -4.05%. That is a compound annual growth rate of -2.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 1.31B | -8.79% |
| Dec 30, 2025 | 1.44B | 5.20% |
| Jan 14, 2025 | 1.37B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novogenia AG | 72.00M |
| 2invest AG | 45.07M |
| Biomark Diagnostics | 33.22M |
| Vidac Pharma Holding | 22.46M |
| Paion AG | 353.12K |
| co.don AG | 240.51K |
| bioXXmed AG | 236.52K |
| MagForce AG | 91.72K |